Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and pegRNA which contains a search sequence, also known as a spacer, which provides a target genomic address for the Prime Editor. The company has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. Prime Medicine, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Prime Medicine Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medi...

Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)

JonesTrading analyst Boris Peaker reiterated a Buy rating on Prime Medicine, Inc. today and set a price target of $5.00. According to TipRanks, Pea...

JonesTrading Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prim...

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prime Medicine, Inc. (PRME)

In a report released today, from Wedbush maintained a Buy rating on Prime Medicine, Inc., with a price target of $8.00. In addition to Wedbush, Pri...

Wedbush Keeps Their Buy Rating on Prime Medicine, Inc. (PRME)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Prime Medicine, Inc. (PRME), Evolent Health (EVH) an...

Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Evolent Health (EVH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Whitehawk Therapeutics (WHWK), Prime Medicine, Inc...

Market Cap	$731.07M	P/E Ratio	N/A
52W High	$6.94	52W Low	$1.18
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	31.4%	52W Position	32.6%
Overall Score	56	Value Score	55
Quality Score	42	Technical Score	72

EPS Current Est	$-0.98	EPS Next Est	$-0.92
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRME	$3.06	-11.82%	4.49M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRME	$3.06	-11.8%	4.49M
3
4
5
6

PRME

PRME

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Prime Medicine Inc. Data in Excel

Get Prime Medicine Inc. Data in Excel